Liberation Bioindustries

What Liberation Bioindustries does

Liberation Bioindustries, formerly Liberation Labs, is a US-based biomanufacturing infrastructure company founded in 2022 that designs, builds, and operates purpose-built precision fermentation facilities as a neutral contract manufacturer. The company's flagship facility in Richmond, Indiana — the first commercial-scale, purpose-built precision fermentation plant of its kind in the US — will offer 600,000 liters of initial fermentation capacity with integrated downstream processing when operations commence in 2026. Liberation serves biotech and consumer-facing companies across food and consumer goods, specialty chemicals and pharmaceuticals, and industrial inputs and advanced materials, offering Biomanufacturing-as-a-Service through long-term take-or-pay agreements and capacity reservations under its proprietary Bio3™ [Design, Build, Operate] platform.

The company's technology stack centers on precision fermentation at industrial scale, using large bioreactors (150,000-liter and 500,000+ liter units) and integrated downstream processing to produce high-value compounds. The Bio3 platform is positioned as a modular, replicable design-build-operate methodology intended for rapid geographic replication. Liberation holds registered trademarks on its brand identity, the Liberation Labs legacy mark, and the Bio3 platform. Its primary physical asset is the Richmond plant, with early-stage engineering underway for a second facility in the Kingdom of Saudi Arabia in partnership with Topian (NEOM Food Company).

Liberation generates revenue through managed-services contract manufacturing fees, with bespoke per-customer pricing negotiated under multi-year take-or-pay agreements and capacity reservation deals. It has secured over 50% of Richmond nameplate capacity under contract or in late-stage agreements, with Vivici (a Dutch ingredients startup producing Vivitein™ BLG dairy protein) named as its first and anchor customer. The company has raised over $376M cumulatively through seed, Series A, equipment financing, USDA-backed debt, and convertible instruments, with key investors including Agronomics, Siddhi Capital, CPT Capital, and the NEOM Investment Fund. Its go-to-market relies on direct enterprise sales supported by thought leadership content via the Inside Biomanufacturing newsletter and industry event participation.

Name

Liberation Bioindustries

Legal name

Liberation Bioindustries, Inc.

Website

https://liberation.bio

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Liberation Bioindustries is a US-based contract manufacturer that designs, builds, and operates purpose-built precision fermentation facilities, serving biotech, food, pharmaceutical, and industrial customers through its Biomanufacturing-as-a-Service model anchored by a 600,000-liter Richmond, Indiana plant.

Ownership category

akta.pro rank

Product category

Contract Biomanufacturing / Precision Fermentation Services

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Food And Kindred Products (2000), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Biorefinery Technology & Contract Processing (fractionation, tolling, scale-up) (IMAMALAL)

akta.pro secondary industries

Biofuels & Renewable Fuels Switching (Biomethane/RNG, Bio-oils, Sustainable Biomass) (EUABAJAD), Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery) (HLAAAFAJ)

Keywords

• Precision fermentation
• Contract biomanufacturing
• Biomanufacturing infrastructure
• Industrial biotechnology
• Fermentation capacity services

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Infrastructure, Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Manufacturing (BaaS): Liberation operates as a contract manufacturer offering Biomanufacturing-as-a-Service (BaaS) through long-term partnerships and take-or-pay agreements. Customers gain capital-light access to world-class fermentation and purification capacity, backed by robust quality systems, feedstock sourcing, and production reliability. The company provides design, build, and operate services for precision fermentation infrastructure.
2. Capacity Reservation Agreements: Capacity reservations allow customers to secure fermentation capacity in advance, providing revenue visibility and ensuring production slots are available when needed.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Liberation Bioindustries is a contract manufacturer offering Biomanufacturing-as-a-Service (BaaS) through purpose-built, commercial-scale precision fermentation facilities. The company produces specialized ingredients for customers across food, pharmaceuticals, specialty chemicals, plastics, biofuels, and other sectors using its proprietary Bio3 Design-Build-Operate platform, with 600,000+ liters of initial fermentation capacity and integrated downstream processing.

Differentiator

Problem solved

Functional benefit

Products and services

• Biomanufacturing-as-a-Service (BaaS) Contract Manufacturing End-to-end contract manufacturing service that produces specialized ingredients via precision fermentation at commercial scale, providing customers with design, build, and operate capacity without the capital outlay of building their own facilities. Long-term partnerships and take-or-pay agreements give customers access to 600,000+ liters of fermentation capacity, integrated downstream processing, robust quality systems, feedstock sourcing, and production reliability.
• Capacity Reservation Agreements A reservation product that lets customers secure fermentation production slots at Liberation's facilities in advance, providing committed capacity, revenue visibility, and prioritized scheduling for their precision-fermented product programs.

Quantifiable outcome

• Over 50% of nameplate capacity at the Richmond plant under contract or in late stages of agreements
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered core and flagship.

• VivicicoreChannel Partner/ Reseller/ Distributor · 7 May 2025Liberation Bioindustries partnered with Vivici, a Dutch ingredients startup, to manufacture commercial scale volumes of Vivitein™ BLG (beta-lactoglobulin), a dairy protein. This is Liberation's first customer for its Richmond plant, with over 50% of nameplate capacity contracted or in late stages of agreement. The partnership addresses growing global protein demand through precision fermentation.
• Topian (NEOM Food Company)flagshipStrategic or Co-development Partner · 16 April 2025Strategic partnership with Topian - The NEOM Food Company to design and develop an advanced precision fermentation facility in the Kingdom of Saudi Arabia. This project represents a critical step in Liberation's global expansion, supporting regional food security and sustainable production goals through precision fermentation. Planning is currently underway.
• Ivy Tech Community CollegecoreImplementation/ SI/ Consulting Partner · 9 January 2024Partnership to train the biomanufacturing workforce of the future. Ivy Tech Community College provides educational programs and training to support Liberation's workforce needs as the company scales operations in Indiana.
• Purdue UniversitycoreStrategic or Co-development Partner · 29 June 2023Partnership through the Purdue President's Council, empowering the next generation of innovators through alumni engagement and advancement of higher education. Purdue is also a partner in Heartland BioWorks, the Regional Technology and Innovation Tech Hub designated by the U.S. Economic Development Administration focused on bioproduction.
• Heartland BioWorks / U.S. Economic Development AdministrationcoreStrategic or Co-development Partner · 24 January 2023Liberation's Richmond facility is part of the Indiana Regional Technology and Innovation Tech Hub designated by the U.S. Economic Development Administration in 2023, focused on bioproduction. Heartland BioWorks leads the consortium in partnership with Purdue University, Indiana University, and other organizations.

Scale indicators6 records

Recent moves14 records

Expansion highlights6 records

Direct peers

• Cauldron: Australia-based precision fermentation contract manufacturer building large-scale fermentation capacity for partners. Directly comparable to Liberation as a CDMO scaling precision fermentation for food, materials and chemicals customers.
• Culture Biosciences: US-based fermentation CDMO offering bioreactor capacity and bioprocess services to biotech customers. Directly comparable as a contract fermentation manufacturer targeting similar customer profiles.
• Geltor: US precision fermentation company producing animal-free proteins for food and beauty. Comparable in that Geltor operates large-scale precision fermentation for ingredient commercialization, though vertically integrated rather than pure CDMO.

Broad incumbents

• Perfect Day: US precision fermentation leader producing animal-free whey protein. Comparable as a precision fermentation operator at commercial scale in food ingredients, though operates its own brands rather than acting primarily as a CDMO.
• Resilience: US biomanufacturing CDMO offering end-to-end manufacturing services across biologics and advanced therapies. Comparable as a broader biomanufacturing services provider though focused on pharma rather than food/precision fermentation.

Emerging players

• Formo: German precision fermentation startup producing animal-free dairy proteins (casein, whey). Comparable target end-markets and use of precision fermentation; emerging player that could become a Liberation customer or competitor.
• The EVERY Company: US precision fermentation company producing animal-free egg and protein ingredients. Comparable as a precision fermentation ingredient producer with similar target customers (food CPG) and technology base.
• New Culture: US precision fermentation startup producing casein for dairy cheese applications. Comparable technology and target end-market (animal-free dairy) as Liberation's Vivici customer use case.
• Vivici: Dutch precision fermentation startup producing beta-lactoglobulin dairy protein. Liberation's anchor customer and a comparable precision fermentation ingredient company in the same end-market and technology category.

Others

• BioMADE: US Department of Defense-sponsored biomanufacturing innovation institute that operates a Pilot Plant Network. A declared Liberation partner and ecosystem enabler; not a competitor but a comparable node in the US biomanufacturing infrastructure landscape.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/liberation-labs
• Xx.com/lib_labs_inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds9 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Liberation Bioindustries